ArticleCancer medicine2025

Maritoclax Overcomes FBW7 Deficiency-Driven Irinotecan Resistance in Colorectal Cancer by Targeting MCL1.

Qian Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.